Mindray Announces New A-Series Advantage Anesthesia Delivery Platform
MAHWAH, N.J., Jan. 10, 2019
MAHWAH, N.J., Jan. 10, 2019 /PRNewswire-PRWeb/ -- Mindray, a leading developer of next-generation medical technology, is pleased to introduce the new A-Series Advantage Anesthesia Delivery platform, providing a modular, state-of-the-art family of anesthesia solutions. The new series includes the A4, A5 and A7 Advantage systems, enabling Mindray to continue its unwavering commitment to perioperative care.
"The recently launched Advantage platform further enhances Mindray's portfolio of perioperative solutions which help to enrich patient care and improve user satisfaction," said Wayne Quinn, President, Mindray North America. "Our goal is to enable 'better healthcare for all' through development of innovative, best-in-class solutions and this release brings us one step closer to this critical objective."
The A-Series Advantage Series provides customer-focused flexibility to meet clinical and financial requirements as they change over time. Advanced ventilation modes for the most challenging patients, from neonatal to bariatrics, include airway pressure release ventilation (APRV) mode, Synchronized Intermittent Mandatory Ventilation (SIMV-VG), Lung Recruitment support, as well as the OptimizerTM low flow decision support tool. Additionally, the enhanced connectivity and integration capabilities of the Advantage platform allow healthcare facilities to build a standardized network throughout an individual facility or across a large hospital network. As a single source of anesthesia delivery systems, patient monitors, and point-of-care ultrasound systems, Mindray continues to support evolving equipment needs for its customers.
"The A-Series Advantage platform improves workflow and offers high performance in a safe, intuitive and cost-effective anesthesia delivery system," said Quinn. "We look forward to partnering with our valued customers to continue providing advanced medical technology in support of excellence in anesthesia care delivery."
Mindray is a leading developer, manufacturer and marketer of medical devices worldwide. Mindray maintains its global headquarters in Shenzhen, China; North American headquarters in Mahwah, New Jersey; and multiple development facilities and offices in major international markets including an Ultrasound Innovation Center in Silicon Valley. Mindray supplies a broad range of products across three primary business segments, patient monitoring and life support, in-vitro diagnostics, and medical imaging systems. For more information, please visit http://www.mindray.com.